Wikidata

(Q61970161)

English

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma

clinical trial

In more languages

Statements

title
A Phase 2 Study of Sequential Trametinib and GSK2141795 in Relapsed or Refractory Multiple Myeloma (English)
0 references
country
Canada
0 references
start time
30 October 2013
0 references
end time
31 December 2018
0 references
number of participants
74
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61970161&oldid=1896623917"